127 results
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
17 Oct 13
Regulation FD Disclosure
12:00am
from animal lungs – use and innovation limited Technology: The Catalyst for Transformation Cochrane & Revak, Science. 1991 Manalo et al. Pediatr Res … to innovation in neonatology
* AEROSURF® - Market Considerations U.S. market potential for AEROSURF – $600M to $1.0B+ 3 International market
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
23 May 22
The study met its primary endpoint of improved systolic blood pressure (SBP) profile at 6 hours
4:01pm
infusions in our planned extension study as we progress toward a potential new therapeutic innovation for treating cardiogenic shock due to heart failure … innovation to treat SCAI class B cardiogenic shock patients is highly needed. The cardiogenic shock worldwide total market value is estimated to be $1.25
8-K
WINT
Windtree Therapeutics Inc
17 Jun 14
Discovery Labs Receives $1.9 Million Fast Track SBIR Grant from the National Institutes of Health (NIH) to Support AEROSURF® Phase 2a Clinical Study
12:00am
million of a $2.4 million Fast Track Small Business Innovation Research (SBIR) Grant from the National Heart, Lung, and Blood Institute (NHLBI
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
17 Jun 14
Discovery Labs Receives $1.9 Million Fast Track SBIR Grant from the National Institutes of Health (NIH) to Support AEROSURF® Phase 2a Clinical Study
12:00am
million of a $2.4 million Fast Track Small Business Innovation Research (SBIR) Grant from the National Heart, Lung, and Blood Institute (NHLBI
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
30 Oct 14
Discovery Labs Announces Organizational Change and Enhanced
12:00am
, we are excited to leverage Dr. Mazela’s passion for technical innovation in addressing the needs of neonates, including his significant experience
8-K
EX-99.1
3rhu6vutgxyvce4u6
15 Mar 22
Windtree Completes Enrollment of Phase 2 Study of Istaroxime in Early Cardiogenic Shock
7:04am
8-K
EX-99.1
ywwi5tknb8ty
20 Apr 22
Windtree Announces Positive Topline Results from Its
7:07am
8-K
EX-99.1
apbwzwz5r541lins00am
10 Nov 21
Windtree Therapeutics Reports Third Quarter 2021 Financial Results and Provides Key Business Updates
4:05pm
8-K
EX-99.1
xgr6mn7kn6l1cwjt2n
14 Nov 22
Windtree Therapeutics Reports Third Quarter 2022 Financial Results and Provides Key Business Updates
7:33am
8-K
EX-99.1
7sfr5nytq0t9
5 Aug 14
Discovery Labs Reports Second Quarter 2014 Financial Results
12:00am
8-K
EX-99.1
xktk7
22 Mar 11
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
nfuf5r668
3 May 12
Discovery Labs Reports First Quarter 2012 Financial Results
12:00am
8-K
8f9 5nm7q
5 Aug 14
Discovery Labs Reports Second Quarter 2014 Financial Results
12:00am
8-K
EX-99.1
tyf330
9 Feb 11
Other Events
12:00am